Immune-mediated pachymeningitis (Q90287): Difference between revisions
From determinar.ia.br - Determine suas informações
Created a new Item |
Changed label, description and/or aliases in pt-br, en |
||
| description / pt-br | description / pt-br | ||
Paquimeningite hipertrófica devido a um processo imunomediado. A síndrome é caracterizada por espessamento localizado ou difuso da dura-máter, embora todas as três membranas possam estar envolvidas. A dura-máter craniana, dura-máter espinhal ou ambas podem estar envolvidas. As características clínicas refletem a parte do neuroeixo afetada e podem incluir cefaleia, paralisia dos nervos cranianos, ataxia, paraparesia, perda sensitiva e perda do controle do esfíncter. O diagnóstico pode ser confirmado por neuroimagem, análise do líquido cefalorraquiano e biópsia meníngea. | |||
| description / en | description / en | ||
Hypertrophic pachymeningitis due to an immune-mediated process. The syndrome is characterised by localised or diffuse thickening of the dura mater, although all three membranes may be involved. The cranial dura, spinal dura or both may be involved. The clinical features reflect the part of the neuraxis affected and may include headache, cranial nerve palsies, ataxia, paraparesis, sensory loss and loss of sphincter control. Diagnosis may be confirmed by neuroimaging, spinal fluid analysis and meningeal biopsy. | |||
Revision as of 17:14, 15 August 2026
Hypertrophic pachymeningitis due to an immune-mediated process. The syndrome is characterised by localised or diffuse thickening of the dura mater, although all three membranes may be involved. The cranial dura, spinal dura or both may be involved. The clinical features reflect the part of the neuraxis affected and may include headache, cranial nerve palsies, ataxia, paraparesis, sensory loss and loss of sphincter control. Diagnosis may be confirmed by neuroimaging, spinal fluid analysis and meningeal biopsy.
| Language | Label | Description | Also known as |
|---|---|---|---|
| default for all languages | ID_1948607488 |
||
| English | Immune-mediated pachymeningitis |
Hypertrophic pachymeningitis due to an immune-mediated process. The syndrome is characterised by localised or diffuse thickening of the dura mater, although all three membranes may be involved. The cranial dura, spinal dura or both may be involved. The clinical features reflect the part of the neuraxis affected and may include headache, cranial nerve palsies, ataxia, paraparesis, sensory loss and loss of sphincter control. Diagnosis may be confirmed by neuroimaging, spinal fluid analysis and meningeal biopsy. |
